drugset
drugset / Trial / NCT05952050

Different Administration Routes of Dexmedetomidine on Postoperative Delirium

NCT05952050 ↗

Unknown 120 enrolled Boston Intelligent Medical Research Center, Shenzhen United Scheme Technology Co., Ltd. Zhongshan Hospital Of Traditional Chinese Medicine · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

Intravenous dexmedetomidine has been reported to decrease the occurrence of postoperative delirium (POD) in elderly patients. Nevertheless, some previous studies have indicated that intratracheal dexmedetomidine and intranasal dexmedetomidine are also effective and convenient. The current study aimed to compare the effect of different administration routes of dexmedetomidine on POD in elderly patients.

Timeline

Start
2023-08-01
Primary completion
2023-08-01
Completion
2023-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified — Intranasal

Indications

delirium